Edward Patz

Edward Patz

Company: Grid Therapeutics

Job title: Chief Executive Officer


Edward Patz, Jr. is the CEO of Grid Therapeutics, a clinical stage biotech company developing novel human derived antibodies from single B cells. Dr. Patz is also the James and Alice Chen Professor of Radiology and a Professor in Pharmacology and Cancer Biology at Duke University Medical CenterFor over 25 years he has been the principal investigator of a cancer biology laboratory, exploring early tumor detection and the host response to cancer. He has a unique perspective on translational projectwith the ultimate goal to improve patient care and outcomes. 

He began his training in High Energy Physics at Harvard University, received his MD from the University of Maryland, and completed his Residency and Thoracic Imaging fellowship at the Brigham and Women’s Hospital and Harvard Medical School. In 1991, hwas recruited to the Thoracic Imaging section in the Department of Radiology at Duke, and in 2016 co-founded Grid Therapeutics. 


Complement Factor H as a Novel Therapeutic Target in Cancer 9:00 am

Download the Full Event Guide to find out more Read more

day: Day One

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.